High Purity Pharmaceutical Qib 179324-69-7 Bortezomib rau Tumor Treatment
Khoomnpe | Bortezomib |
Synonyms | [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid |
CAS Nr. | 179324-69-7 |
Qhov tshwm sim | Dawb los yog dawb hmoov hmoov |
Molecular Formula | C19H25BN4O4 |
Molecular Luj | 384.24 ib |
Kev siv | Pharmaceutical qib lossis lub hom phiaj tshawb fawb |
Ntim | Raws li koj qhov kev thov |
Cia | Khaws nyob rau hauv nruj, lub teeb-resistant ntim nyob rau hauv ib qhov chaw txias |
Yam khoom | STANDARDS | TSEEM CEEB |
Character | Dawb los yog dawb hmoov hmoov | Dawb hmoov |
Poob rau ziab | ≤ 1.0% | 0.25% |
Hnyav Hlau | ≤ 20ppm | 20 ppm |
Kev hloov kho qhov muag | -45 ° ~ -55 ° | -53.2 ° |
Yam khoom muaj feem | Tag nrho cov impurities ≤ 1.0% | 0.09% |
Tsis pom zoo impurity ≤ 0.10% | 0.02% | |
Residual Solvents | Methanol ≤ 0.3% Dichloromethane ≤ 0.06% Hexane ≤ 0.029% ethyl acetate ≤ 0.5% | ND ND ND 0.030% |
QHIA | ≥ 99.0% | 99.91% |
Xaus: Nws ua raws li tus qauv hauv tsev. |
Cov ntaub ntawv tuam txhab
√ Kev tswj cov txheej txheem tag nrho hauv lub Hoobkas thiab cov kws tshaj lij cov neeg ua haujlwm; √ Zoo yog ib txwm peb xav txog sab saum toj, nruj QC system; √ 11 xyoo dhau los ntawm pab pawg muag khoom; √ Kev ywj pheej R & D lab; √ Ob qhov kev kos npe mus sij hawm ntev GMP kev cob qhia; √ Cov peev txheej nplua nuj ntawm ntau lub chaw ua haujlwm tsis ua haujlwm rau qhov project customized; √ Pab neeg ua haujlwm siab ua haujlwm nrog txoj hauv kev zoo ib yam.Sau koj cov lus ntawm no thiab xa tuaj rau peb